SQUAMOUS CELL CARCINOMA OF HEAD AND NECK

This adverse event was reported 230 times

These drugs are most commonly taken by patients reporting SQUAMOUS CELL CARCINOMA OF HEAD AND NECK:

# Drug Count
0 CETUXIMAB 25
1 CISPLATIN 21
2 CARBOPLATIN 20
3 METHOTREXATE SODIUM 20
4 METHOTREXATE 19
5 LENALIDOMIDE 17
6 DEXAMETHASONE 15
7 DEXAMETHASONE 1.5 MG 15
8 OMEPRAZOLE MAGNESIUM 15
9 OMEPRAZOLE 14
See all common drugs associated with SQUAMOUS CELL CARCINOMA OF HEAD AND NECK

SQUAMOUS CELL CARCINOMA OF HEAD AND NECK is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DOXYCYCLINE MONOHYDRATE 2 0.0013
1 ALDESLEUKIN 1 0.0008
2 CETUXIMAB 25 0.0008
3 IODIUM,BADIAGA,FUCUS VESICULOSUS,CALCAREAARSENICUM IODATUM, THYROIDINUM,CARBONICA,PULSATILLA,BARYTA CARBONICA, 2 0.0007
4 SCOPOLAMINE 2 0.0005
5 CLINDAMYCIN PHOSPHATE 3 0.0005
6 TOFACITINIB CITRATE 5 0.0004
7 TOPOTECAN 2 0.0003
8 CISPLATIN 21 0.0003
9 PROCHLORPERAZINE MALEATE 2 0.0002
See all drugs enriched for association with SQUAMOUS CELL CARCINOMA OF HEAD AND NECK